ATR
AptarGroup, Inc.
ATR's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over ATR overall, supported by stronger modeled upside and lower modeled downside.
ATR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Healthy |
ATR's balance sheet is currently healthy, and its revenue, profitability and cash flow are stable.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ATR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $142 | — |
| Cheap | 24x | $100 | -29% |
| Fair | 32x | $131 | -7.7% |
| Current | 34x | $142 | — |
| Expensive | 35x | $145 | +2.1% |
Historical ranges are pointers, not guarantees.
ATR has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
ATR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
ATR has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
ATR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.08 | +48% |
| Q3 2026 | $4.12 | -34% |
| Q2 2026 | $5.53 | -4.7% |
| Q1 2026 | $5.84 | +6.8% |
| Q4 2025 | $5.89 | +6.5% |
| Q3 2025 | $6.24 | +25% |
| Q2 2025 | $5.80 | +22% |
| Q1 2025 | $5.47 | +17% |
| Q4 2024 | $5.53 | +30% |
ATR has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
ATR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1B | +6% |
| Q2 2026 | $1B | +6.3% |
| Q1 2026 | $982.9M | +11% |
| Q4 2025 | $962.7M | +14% |
| Q3 2025 | $961.1M | +5.7% |
| Q2 2025 | $966M | +6.1% |
| Q1 2025 | $887.3M | -3.1% |
| Q4 2024 | $848.1M | +1.1% |
ATR's revenue has grown year over year for six quarters in a row: $1B last quarter, up 6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | -1 points |
| Q2 2026 | 12% | -2.6 points |
| Q1 2026 | 11% | -1.8 points |
| Q4 2025 | 11% | -3.1 points |
| Q3 2025 | 14% | -1 points |
| Q2 2025 | 15% | +1.1 points |
| Q1 2025 | 13% | +0.5 points |
| Q4 2024 | 14% | +4.1 points |
ATR has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over ATR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
ATR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $98.6M | -14% |
| Q2 2026 | $45.9M | -27% |
| Q1 2026 | $53.3M | +106% |
| Q4 2025 | $96.9M | -14% |
| Q3 2025 | $114.3M | -30% |
| Q2 2025 | $62.5M | -17% |
| Q1 2025 | $25.9M | +55% |
| Q4 2024 | $112.2M | -19% |
ATR's free cash flow has been positive every quarter for seven years: $295M over the past year, down 6.4% from the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over ATR on cash flow, with more consistent year-over-year improvement.
ATR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -61K shares |
| 1 year | -3.7% | -2.5M shares |
| 3 years | -4.3% | -2.9M shares |
| 5 years | -5.4% | -3.7M shares |
| Available history | -3.1% | -2M shares |
ATR has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $30M |
| Q2 2026 | $50M |
| Q1 2026 | $100M |
| Q4 2025 | $175M |
| Q3 2025 | $40M |
| Q2 2025 | $70M |
| Q1 2025 | $80M |
| Q4 2024 | $37.3M |
ATR spent $355M buying back its own shares over the past year, up 56% from the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
ATR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.1x | Healthy |
ATR has the edge over UNH on leverage, with a lower net debt burden relative to earnings.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
ATR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.9 | Neutral |
| Stochastic | 78.5 | Neutral |
ATR's weekly RSI is 65 (neutral) and its Stochastic is 79 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
ATR PE vs Healthcare Sector
| Metric | ATR | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 26x | 33% above |
| PE % | 80 | 29 | 51 pts above |
ATR is trading at 34x earnings, a 33% premium to the Healthcare sector's median of 26x.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over ATR on valuation relative to its sector.
ATR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $129.6 | 9.4% above |
| 20 week MA | $130.0 | 9% above |
| 50 week MA | $127.1 | 11% above |
| 100 week MA | $135.9 | 4.3% above |
| 200 week MA | $135.3 | 4.8% above |
ATR has the edge over UNH on trend strength, trading above more of its moving averages.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
ATR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $115.0 | $135.7 | +18% |
| 2021 | $135.7 | $116.3 | -14% |
| 2022 | $116.3 | $110.0 | -5.4% |
| 2023 | $110.0 | $123.6 | +12% |
| 2024 | $123.6 | $158.2 | +28% |
| 2025 | $158.2 | $123.3 | -22% |
| 2026 YTD | $123.3 | $141.7 | +15% |
ATR has finished lower in three of the last six years. It's up 15% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over ATR on returns for 2026, with the stronger performance.